AFP and hepatocellular carcinoma: Recognizing this limitation, we developed alternative, highly accurate diagnostic models: notably, the miR-200a-3p/AFP combination achieves an AUC > 0.9 for differentiating HCC from CHB/cirrhosis, fulfilling the need for precise HCC detection in high-risk cirrhotic patients.